Ignite Creation Date:
2025-12-24 @ 11:00 PM
Ignite Modification Date:
2026-01-02 @ 1:42 PM
Study NCT ID:
NCT03853369
Status:
UNKNOWN
Last Update Posted:
2019-03-14
First Post:
2019-02-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Post-marketing Registration Study of Nifekalant Hydrochloride (NIF) Injection
Sponsor:
Sichuan Baili Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-02-18
Start Date Type:
ACTUAL
Primary Completion Date:
2019-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2019-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2019-02-13
First Submit QC Date:
None
Study First Post Date:
2019-02-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-12
Last Update Post Date:
2019-03-14
Last Update Post Date Type:
ACTUAL